FDA官网 https://endpts.com/every-fda-drug-approval-from-2023-full-list-of-approved-new-drugs/ 免费领取药智数据VIP试用:https://vip.yaozh.com/introducemobile?tryout=1&ga_source=zimeiti&ga_name=yzw_wz
Overviews of the New Drugs in 2024 Approved by U.S. FDA 2024年美国FDA批准上市新药简介 韩博1,2,3,张庆伟1,2,3* 摘要 2024 年美国FDA 批准上市新药50 个,其中小分子药物31 个,生物制品19 个。根据FDA 批准的新药说明书以及相关数据库和专利检索情况,文章简要介绍了2024 年FDA 批准的上市小分子药物的...
However, the study was also quick to point out that the FDA's current process is working. "The fact that the FDA is issuing safety communications means it is doing a good job of following newly approved drugs and evaluating their safety up in the post-market period," Ross noted....
Current FDA-Related Drug Information - New Drugs Approved by the FDA; New Dosage Forms and Indications Approved by the FDA; Agents Pending FDA Approval; New Drug Applications Filed by Manufacturer; Supplemental Applications Filed by Manufacturer; Significant Labeling Changes or 鈥淒ear Health Care ...
[1] FDA approves datopotamab deruxtecan-dlnk for unresectable or metastatic, HR-positive, HER2-negative breast cancer. Retrieved January 17, 2025 from https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-datopotamab-deruxtecan-dlnk-unresectable-or-metastatic-hr-positive-...
Ahead of us in June,it is anticipated FDA will make decisions on the following four drugs. Drug: spesolimab Company: Boehringer Ingelheim Indication: generalized pustular psoriasis Boehringer Ingelheim’s spesolimab is a humanized, selective antibody that blocks the activation of the interleukin-36...
Now, the Food and Drug Administration(FDA) has approved two drugs that may slow the cognitive decline destroying the lives of millions of Alzheimer’s patients. But both approvals are highly controversial. They were only based on the drugs’ ability to remove plaques (斑块), which were thought...
New Drugs Approved by the FDA; New Dosage Forms and Indications; Agents Pending FDA Approval; Market Withdrawals; Major Labeling Changesdoi:10.1177/001857879903400712DanialE.BakerSageHospital Pharmacy
Ahead of us in June,it is anticipated FDA will make decisions on the following four drugs. Drug: spesolimab Company: Boehringer Ingelheim Indication: generalized pustular psoriasis Boehringer Ingelheim’s spesolimab is a humanized, selective antibody that blocks the activation of the interleukin-36...
New Drugs Approved by the FDANew Dosage Forms and Indications Approved by the FDAAgents Pending FDA ApprovalNew Drug/Biologies License Applications Filedby ManufacturerSignificant Labeling Changes or 'Dear Health Care Professional' Letters Related to Safety 机译:FDA批准的新药FDA批准的FDA代理商批准的新...